Factors associated with glycemic variability in children with type 1 diabetes mellitus based on flash glucose

Liyin Zhang1, Keyu Guo2, Yaling Xu2

  • 1Department of Endocrinology & Metabolism, Second Xiangya Hospital, Central South University, Changsha 410011. 198211060@csu.edu.cn.

Insights

Children with type 1 diabetes mellitus (T1DM) in China face high risks of hypoglycemia and glycemic variability. Shorter diabetes duration, better HbA1c control, frequent glucose monitoring, and insulin pump use improve glycemic control.

Area of Science:

  • Pediatrics
  • Endocrinology
  • Metabolic Diseases

Background:

  • Type 1 diabetes mellitus (T1DM) in children necessitates lifelong insulin therapy due to pancreatic beta-cell destruction.
  • T1DM incidence is rising rapidly among Chinese children, with suboptimal glycemic control (low HbA1c and compliance) observed.
  • Effective glucose management is crucial for preventing long-term vascular complications in T1DM patients.

Purpose of the Study:

  • To assess glycemic control in children with T1DM in Hunan and Henan Provinces using a flash glucose monitoring system (FGMS).
  • To identify factors associated with glycemic variability in this pediatric T1DM population.

Main Methods:

  • A cohort of 215 children (under 14 years) with T1DM were monitored using FGMS across 16 hospitals (August 2017 - August 2020).
  • Data collected included HbA1c, diabetes duration, glucose scan rates, and glycemic variability metrics (e.g., MAGE, TIR, TBR).
  • Statistical analyses explored correlations between glycemic control parameters and variability, comparing different diabetes durations, HbA1c levels, scan rates, and insulin regimens.

Main Results:

  • Higher HbA1c and longer diabetes duration correlated with increased glucose variability (mean blood glucose, SD, MAGE, CV).
  • Higher glucose scan rates were linked to improved time in range (TIR) and reduced MAGE and hypoglycemia.
  • Shorter diabetes duration, lower HbA1c, frequent scanning (≥14 times/day), and continuous subcutaneous insulin infusion (CSII) were associated with better glycemic control and less variability.

Conclusions:

  • Pediatric T1DM patients in Hunan and Henan exhibit significant risks of hypoglycemia and high glycemic variability.
  • Factors promoting better glycemic control include shorter diabetes duration, achieving target HbA1c levels, frequent glucose scanning, and utilizing CSII.
Abstract

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.0K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.3K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
734
Glucose Homeostasis: Regulation of Blood Glucose01:02

Glucose Homeostasis: Regulation of Blood Glucose

Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
2.6K
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
360
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
282